COSMED enters into a global distribution agreement with BOSCH Healthcare Division
Rome (Italy) - May 2017 - We are glad to inform you that COSMED has recently signed an agreement with BOSCH Healthcare Solutions GmbH for the distribution of their new FeNO device.
The new Vivatmo device, manufactured from Bosch Healthcare, measures the NO-content in exhaled breath. FeNO (fractional exhaled nitric oxide) is a biomarker for eosinophile airway inflammation and reflects the inflammatory activity of allergic bronchial asthma. The quick, painless and noninvasive analysis method is a reliable way of monitoring allergic airway inflammation in asthma patients.
Vivatmo measures the concentration of fractional exhaled nitric oxide (FeNO) in people with chronically inflamed airway diseases, such as allergic asthma. Patients can use Vivatmo me to monitor their treatment themselves, and can provide their physician with valuable information about the course of the disease and their response to treatment. This enables close monitoring of the patient’s condition and, if necessary, a rapid adjustment of treatment.
The Vivatmo system consists of Vivatmo pro, the device for physicians; Vivatmo me, the device for patients; and a Vivatmo app, developed especially for the patient device. This app wirelessly transmits the measured data via Bluetooth to the patient’s smartphone, from where the information can be sent to the attending physician. When used in conjunction with the measurements made by Vivatmo pro, Vivatmo me’s non-invasive technique can also help lower the exacerbation rate of asthma and in turn possibly reduce the administration of anti-inflammatory medication for this chronic condition, such as inhaled corticosteroids.
With the Vivatmo system, Bosch is now bringing recognized exhaled breath measurement from the physician’s office straight into patients’ homes. Thus, the Vivatmo system creates the prerequisites for the best possible therapy and monitoring of the condition.
About Bosch Healthcare Solutions
Bosch Healthcare Solutions develops and markets products and services that promote health. More than 80 associates are currently employed at the company’s headquarters in Waiblingen. The Bosch Healthcare Solutions portfolio draws heavily on the Bosch Group’s core competencies: sensors to collect data, software to evaluate that data, and services based on this data analysis. In all product development, strong partners provide a wealth of expertise: Bosch’s corporate sector for research and advance engineering provides the scientific basis for developing new products, while the Robert Bosch Hospital in Stuttgart lends its support in the development and testing of new healthcare solutions. In addition to Vivatmo, Bosch Healthcare Solutions will offer customers further connected products and services in the areas of healthcare and medical technology.
